We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Aredia Plaintiffs Slam Novartis Bid For Ex-Parte Talks

Law360 (December 7, 2007, 12:00 AM EST) -- Efforts by Novartis Pharmaceuticals Corp. to meet with treating physicians during the discovery phase of litigation over its bone cancer drugs have met with stiff opposition by the plaintiffs steering committee.

The committee filed an objection to the drug maker's motion for permission to engage in ex parte talks with the plaintiffs' doctors on Thursday in the U.S. District Court for the Middle District of Tennessee. The committee said Novartis did not offer facts to justify compelling a waiver of the plaintiffs' doctor-patient privileges.

Describing the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.